Posted by Michael Wonder on 18 Dec 2022
On Target Laboratories announces expanded indication of Cytalux (pafolacianine) injection for detection of lung cancer during surgery
16 December 2022 - Cyralux is also the first and only targeted molecular imaging agent that illuminates ovarian cancer in real time during surgery.
On Target Laboratories today announced that the US FDA has approved an expanded indication for the use of Cytalux in lung cancer.
